Medicinal and Biomolecular Chemistry articles for Shanghai Jiao Tong University (SJTU), China

Time frame: 1 June 2025 - 30 May 2026

View topic

Count: 28

Article ‘Count’ for Medicinal and Biomolecular Chemistry.

Journal Count Share
1 0.04
Molecular Engineering of DNA Condensates: Harnessing Phase Transitions for Precise Control of Catalytic Functions 0.04
1 0.93
ZnS/Au Composites Advance Comprehensive Characterization of Low-Molecular-Weight Compounds Toward Pharmaceutical Analysis of Traditional Chinese Medicine 0.93
1 0.07
Natural Design of a Stabilized Cross-β Fold: Structure of the FuA FapC from Pseudomonas Sp. UK4 Reveals a Critical Role for Stacking of Imperfect Repeats 0.07
1 1.00
In Situ Study of p53, MDM2, and MDMX Protein Interaction in Living Cells Using Fluorescence Triple Correlation Spectroscopy 1.00
4 2.36
Ribosomal Synthesis of Topologically Defined Thioisoindole‐Bridged Bicyclic Peptides 0.13
Synergistic SuFEx-Driven Covalent Cancer Therapy Using a HER2/EGFR Bivalent Affinity Protein Drug 0.90
A Picolyl-Based Cys Caging/Uncaging Strategy Facilitates Protein Synthesis 0.56
Pd-Catalyzed Stereospecific and Ligand-Controlled Regiodivergent Suzuki–Miyaura Cross-Coupling for the Synthesis of 3-C-Glycals and 2,3-Unsaturated C-Glycosides 0.78
2 1.06
Design of permeability-optimized target-binding macrocycles via direct preference optimization 0.75
Pd-catalyzed stereoretentive synthesis of reversed C-acyl glycosides: access to rare l-sugars and higher-carbon sugars 0.31
3 1.70
Sustainable Peptide Synthesis by Photoredox-Catalyzed Picoc-SPPS 0.84
Chemical Evolution of Double Covalent Aptamers for Sustained Protein Degradation and Improved Cytotoxicity in NK-Cell-Mediated Tumor Therapy 0.02
Chemically Engineered Affinity Protein Drugs for Covalent Targeted Cancer Therapy 0.83
1 0.17
Aging-Directed Structural Evolution of In Situ Formed Polymeric Coacervates and Their Applications in Constructing Hierarchical Assemblies 0.17
1 0.64
Conformational Adaptability and Thermostability in α/β-Peptide Fibrils Induced by β-Amino Acid Substitution 0.64
1 0.38
PML targets and resolves structured protein inclusions to mitigate neurodegeneration 0.38
8 2.44
Gene-in-gene coding generates dual-isoform Fha condensates to control type VI secretion system assembly 0.04
An orthogonal RNA aptamer for targeted RNA regulation in phase-separated subcellular compartments 0.05
Energy-sensing molecule RORγ regulates cholesterol metabolism and immune signaling in diabetic kidney disease and aging 0.09
Renal insulin-like growth factor binding-protein 7 is a critical promoter of progressive diabetic kidney disease 0.05
Pre-established ATF4 occupancy and chromatin organization instruct selective transcription activation during integrated stress response 1.00
Targeting Msx2 as a brake in the fusion fate of osteoclasts and an anabolic therapy in pre-clinical models of osteoporosis 0.06
RIPK4-mediated MFN2 degradation drives osteogenesis through mitochondrial fragmentation and restricts myelopoiesis by blocking mitochondrial transfer 0.97
Engineering bi-directional chemically-modulated synthetic condensates for cellular control 0.18
1 0.07
Condensate protein aggregation in ALS/FTD is regulated by GGGGCC-repeat RNA scaffolds 0.07
2 0.56
CDKL5 modulates the plasticity of excitatory synapses via liquid–liquid phase separation 0.31
De novo design of protein binders to stabilize monomeric TDP-43 and inhibit its pathological aggregation 0.25
1 0.02
Nanoscale Mechanical Force Primes NOD1-LRR for Efficient Pathogen Recognition 0.02

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.